TR200002801T2 - PDE IV engelleyici piridin türevleri - Google Patents

PDE IV engelleyici piridin türevleri

Info

Publication number
TR200002801T2
TR200002801T2 TR2000/02801T TR200002801T TR200002801T2 TR 200002801 T2 TR200002801 T2 TR 200002801T2 TR 2000/02801 T TR2000/02801 T TR 2000/02801T TR 200002801 T TR200002801 T TR 200002801T TR 200002801 T2 TR200002801 T2 TR 200002801T2
Authority
TR
Turkey
Prior art keywords
pde
pyridine derivatives
blocking
compounds
formula
Prior art date
Application number
TR2000/02801T
Other languages
English (en)
Inventor
Jean Edgard Freyne Eddy
Stanislas Marcella Diels Gaston
Encarnacion Matesanz-Ballesteros Maria
Diaz-Martinez Adolfo
Original Assignee
Janssen Pharmaceutica N.V.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica N.V. filed Critical Janssen Pharmaceutica N.V.
Publication of TR200002801T2 publication Critical patent/TR200002801T2/tr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing three or more hetero rings

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

Bu bulus, PDE IV sitokin engelleyici etkinlige sahip, (I) formülüne sahip olan piridin türevlerine, bu türevlerin N-oksit biçimlerine, farmasötik olarak kabul edilebilir ilave tuzlari ve stereokimyasal açidan izomerik biçimlerine iliskindir. Bulus, ayni zamanda, (I) formülünün bilesiklerinin hazirlanmasi için islemlere, bu bilesiklerin farmasötik bilesimleri ve bu bilesiklerin bir tibbi madde olarak kullanimina da iliskindir.
TR2000/02801T 1998-04-01 1999-03-24 PDE IV engelleyici piridin türevleri TR200002801T2 (tr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP98201020 1998-04-01

Publications (1)

Publication Number Publication Date
TR200002801T2 true TR200002801T2 (tr) 2000-12-21

Family

ID=8233543

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2000/02801T TR200002801T2 (tr) 1998-04-01 1999-03-24 PDE IV engelleyici piridin türevleri

Country Status (34)

Country Link
US (1) US6656959B1 (tr)
EP (1) EP1068194B1 (tr)
JP (1) JP4778612B2 (tr)
KR (1) KR100596664B1 (tr)
CN (1) CN1172930C (tr)
AR (1) AR014972A1 (tr)
AT (1) ATE253569T1 (tr)
AU (1) AU760771B2 (tr)
BG (1) BG64705B1 (tr)
BR (1) BR9909326A (tr)
CA (1) CA2326045C (tr)
CZ (1) CZ298747B6 (tr)
DE (1) DE69912590T2 (tr)
DK (1) DK1068194T3 (tr)
EA (1) EA004207B1 (tr)
EE (1) EE04718B1 (tr)
ES (1) ES2211061T3 (tr)
HK (1) HK1033579A1 (tr)
HR (1) HRP20000619B1 (tr)
HU (1) HU229412B1 (tr)
ID (1) ID27207A (tr)
IL (2) IL138745A0 (tr)
MY (1) MY124696A (tr)
NO (1) NO319531B1 (tr)
NZ (1) NZ507022A (tr)
PL (1) PL196026B1 (tr)
PT (1) PT1068194E (tr)
SI (1) SI1068194T1 (tr)
SK (1) SK284468B6 (tr)
TR (1) TR200002801T2 (tr)
TW (1) TWI242558B (tr)
UA (1) UA66842C2 (tr)
WO (1) WO1999050262A1 (tr)
ZA (1) ZA200006190B (tr)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MY123585A (en) 2000-03-23 2006-05-31 Merck Canada Inc Tri-aryl-substituted-ethane pde4 inhibitors.
US6639077B2 (en) 2000-03-23 2003-10-28 Merck Frosst Canada & Co. Tri-aryl-substituted-ethane PDE4 inhibitors
DE10130397A1 (de) * 2001-06-23 2003-01-09 Bayer Cropscience Gmbh Herbizide substituierte Pyridine, Verfahren zu ihrer Herstellung und ihre Verwendung als Herbzide und Pflanzenwachstumsregulatoren
DE10318610A1 (de) * 2003-04-24 2004-11-11 Elbion Ag 7-Azaindole und deren Verwendung als Therapeutika
AU2005238296A1 (en) 2004-04-30 2005-11-10 Warner-Lambert Company Llc Substituted morpholine compounds for the treatment of central nervous system disorders
US7863446B2 (en) 2006-01-19 2011-01-04 Orchid Research Laboratories Limited Heterocycles
US8354434B2 (en) 2006-01-30 2013-01-15 Purdue Pharma L.P. Cyclourea compounds as calcium channel blockers
DE602007011793D1 (de) 2006-10-18 2011-02-17 Pfizer Prod Inc Biaryl-ether-harnstoffverbindungen
BRPI0912029A2 (pt) 2008-02-01 2020-06-30 Orchid Research Laboratories Limited novos heterociclos
JOP20190060A1 (ar) 2016-09-26 2019-03-26 Chugai Pharmaceutical Co Ltd مشتق بيرازولو بيريدين له تأثير مساعد لمستقبل glp-1

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3876657A (en) * 1971-06-03 1975-04-08 Ashland Oil Inc Preparation of 1-substituted-2-imidazolidinones
US4600430A (en) 1985-02-22 1986-07-15 Eli Lilly And Company Pyridinylimidazolidinone compounds
PT711282E (pt) * 1993-07-28 2002-11-29 Aventis Pharma Ltd Compostos inibidores de pde iv e de fnt
GB9401460D0 (en) * 1994-01-26 1994-03-23 Rhone Poulenc Rorer Ltd Compositions of matter
WO1996004186A1 (en) * 1994-08-03 1996-02-15 Gics & Vermee, L.P. Ovenable food package
TW424087B (en) 1995-04-06 2001-03-01 Janssen Pharmaceutica Nv 1,3-dihydro-1-(phenylalkenyl)-2H-imidazol-2-one derivatives
TW332201B (en) 1995-04-06 1998-05-21 Janssen Pharmaceutica Nv 1,3-Dihydro-1-(phenylalkyl)-2H-imidazol-2-one derivatives
TW375612B (en) 1995-04-06 1999-12-01 Janssen Pharmaceutica Nv 1,3-dihydro-2H-imidazol-2-one derivatives for the treatment of disease states related to an abnormal enzymatic or catalytic activity of phosphodiesterase type IV, preparation thereof and pharmaceutical composition containing the same
WO1997003967A1 (en) 1995-07-22 1997-02-06 Rhone-Poulenc Rorer Limited Substituted aromatic compounds and their pharmaceutical use
IL125034A0 (en) * 1995-12-29 1999-01-26 Smithkline Beecham Corp Vitronectin receptor antagonists
CZ297474B6 (cs) 1996-10-02 2006-12-13 Janssen Pharmaceutica N. V. Deriváty 2-kyaniminoimidazolu inhibující PDE IV

Also Published As

Publication number Publication date
DK1068194T3 (da) 2004-03-15
CN1295571A (zh) 2001-05-16
NZ507022A (en) 2002-06-28
KR20010040681A (ko) 2001-05-15
BG64705B1 (bg) 2005-12-30
HRP20000619A2 (en) 2001-10-31
JP2002509927A (ja) 2002-04-02
ES2211061T3 (es) 2004-07-01
EP1068194A1 (en) 2001-01-17
SK13872000A3 (sk) 2001-11-06
BR9909326A (pt) 2000-12-12
AU760771B2 (en) 2003-05-22
CA2326045A1 (en) 1999-10-07
ID27207A (id) 2001-03-08
EE200000569A (et) 2002-04-15
MY124696A (en) 2006-06-30
US6656959B1 (en) 2003-12-02
CA2326045C (en) 2008-12-09
JP4778612B2 (ja) 2011-09-21
IL138745A0 (en) 2001-10-31
HU229412B1 (en) 2013-12-30
KR100596664B1 (ko) 2006-07-06
ZA200006190B (en) 2001-10-31
DE69912590D1 (de) 2003-12-11
EA200001009A1 (ru) 2001-02-26
AU3147499A (en) 1999-10-18
NO319531B1 (no) 2005-08-29
EA004207B1 (ru) 2004-02-26
NO20004906L (no) 2000-11-28
EE04718B1 (et) 2006-10-16
HK1033579A1 (en) 2001-09-07
SI1068194T1 (en) 2004-04-30
PL196026B1 (pl) 2007-11-30
DE69912590T2 (de) 2004-09-16
WO1999050262A1 (en) 1999-10-07
IL138745A (en) 2007-06-17
AR014972A1 (es) 2001-04-11
SK284468B6 (sk) 2005-04-01
CZ20003338A3 (cs) 2001-02-14
PT1068194E (pt) 2004-03-31
PL343194A1 (en) 2001-07-30
CZ298747B6 (cs) 2008-01-16
BG104718A (en) 2001-04-30
HRP20000619B1 (en) 2004-06-30
HUP0101239A3 (en) 2002-09-30
UA66842C2 (uk) 2004-06-15
ATE253569T1 (de) 2003-11-15
EP1068194B1 (en) 2003-11-05
TWI242558B (en) 2005-11-01
CN1172930C (zh) 2004-10-27
NO20004906D0 (no) 2000-09-29
HUP0101239A2 (hu) 2002-05-29

Similar Documents

Publication Publication Date Title
TR200103186T2 (tr) MEK enzimlerinin inhibitörleri olarak kinolin türevleri
ATE264852T1 (de) Chinolinderivate als antibakterielle mittel
TR200101306T2 (tr) HİV Virüsünün çoğalmasını önleyen pirimidinler
TR200201505T2 (tr) Terapötik maddeler olarak pirazolopirimidinler
TR199902606T2 (tr) Farnesil transferazi engelleyici kinazolinonlar.
ATE452129T1 (de) N-phenyl-2-pyrimidine-amine derivatives
TR200102603T2 (tr) Antitümör aktiviteye sahip olan kamptotesin türevleri
TR200002761T2 (tr) HIV enfeksiyonlarının tedavisi için üç-ikameli 1,3,5-triazin türevleri.
MXPA04012965A (es) Inhibidores virales.
DE60322359D1 (de) Imidazopyridinderivate als kinaseinhibitoren
TR200302242T2 (tr) Protein kinaz önleyicileri olarak pirolopirimidinler
NO20070224L (no) 2-karbamid-4-fenyltiazolderivater, fremstilling og terapeutisk anvendelse derav
TR199900732T2 (tr) PDE IV inhibe eden 2-siyanoiminoimidazol türevleri.
NO20011721D0 (no) N-aralkylaminotetraliner som ligander for neuropeptid Y Y5 reseptor
NO20050573L (no) 4-'7-halo-2-quino (XA) linyloksy ! fenoksypropionsyrederivater som antineoplastiske midler
ATE300541T1 (de) Pyrazolopyridinderivate
ATE233754T1 (de) Diphenyl-piperidin derivate
TR200002801T2 (tr) PDE IV engelleyici piridin türevleri
ATE326451T1 (de) Chinazolin derivate und therapeutische verwendungen davon
PT1095040E (pt) Novos benzoxazoles com actividade inibidora da pde
NO20031410L (no) Anvendelse av distamycinderivater for fremstilling av medikamenter
HUP0401562A2 (hu) Kinolinszármazékok és alkalmazásuk tumorellenes szerekként és ezeket tartalmazó gyógyászati készítmények
PT880520E (pt) Derivados da benzo¬c|quinolizina sua preparacao e uso como inibidores da 5-alfa-reductase
ATE274515T1 (de) Pyrazolopyridinderivate
ATE285771T1 (de) Diaminotrifluoromethylpyrimidinderivate enthaltende antikrebs-zusammensetzung